The company develops generative AI-powered software for medical devices through its MEDHINI platform. The firm provides genomics-based multimodal solutions for healthcare diagnostics, virtual clinical trials, and insurance underwriting across various medical specialties, including oncology and cardiology. Its technology facilitates diagnostics for antimicrobial resistance and analyzes climate change impacts on human health.